share_log

HC Wainwright & Co. Maintains Buy on EyePoint Pharmaceuticals, Maintains $33 Price Target

HC Wainwright & Co. Maintains Buy on EyePoint Pharmaceuticals, Maintains $33 Price Target

HC Wainwright & Co.维持对EyePoint制药的买入,维持33美元的目标股价
Benzinga ·  03/08 13:06

HC Wainwright & Co. analyst Yi Chen maintains EyePoint Pharmaceuticals (NASDAQ:EYPT) with a Buy and maintains $33 price target.

HC Wainwright & Co. 分析师陈毅维持EyePoint Pharmicals(纳斯达克股票代码:EYPT)的买入并维持33美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发